This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Research & Development News

Research & Development news

  • News Parenteral delivery — under control

    In this second article exploring new methods of quantifying and analysing the performance characteristics of controlled release products outlines tests for parenteral forms of controlled delivery systems.
  • News No hiding place for herpes

    Attempts to protect the population from the contagious herpes virus have been hindered by its ability to hide from the body’s immune system. The biotech company BioVex explains how its new vaccine addresses this problem.
  • News Respiratory syncytial virus – ALN-RSV-01

    US biotech Alnylam is taking another tack – it is developing an RNAi-based drug to attack respiratory syncytial virus, or RSV.
  • News Improving trial data management

    Wipro Technologies highlights how its electronic solution has helped to manage a client’s process of data collection and trial management in a cost-effective and efficient way.
  • News No need for the cooler

    The provision of instantly injectable, thermo-stable vaccines in tropical temperatures could make cold storage problems a thing of the past. Nova Bio-Pharma Technologies believes it has the technology.
  • News Heart failure – omecamtiv mecarbil

    Omecamtiv mecarbil1 is being developed by Cytokinetics in collaboration with Amgen.
  • News Knockout medicines

    Dr Sarah Houlton reviews recent development of gene manipulation technology and its potential application in providing new medicines.
  • News Anticoagulant – edoxaban tosilate

    There are several points along the clotting cascade that could be targets for anticoagulants.Edoxaban is being developed by Daiichi Sankyo, and is showing promise in clinical trials.
  • News Making the French connection

    The annual CPHI events move back to Paris next month. Hilary Ayshford questioned the organisers on their expectations for the shows and the future outlook.
  • News Microbial control of combo devices

    New drug delivery systems or ‘combo’ devices are becoming more prevalent in the market. Mark Botting, UK commercial manager, Isotron, reviews some current challenges and potential future changes in sterilising drug device combination products...
  • News Management cost vs value

    Clinical trials are usually tendered for and awarded on cost. Paul Naybour, md at Parallel Project Training, and Roger Joby, project management consultant at 1to1to1, argue that the focus should be on value rather than cost.
  • News What’s in a seal?

    Elastomer maker Precision Polymer Engineering and ChargePoint Technology explain how the optimum elastomer was selected for a split butterfly valve.
  • News International Society for Cellular Therapy (ISCT) launches Cell Therapy Industry Partnership

    Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment ...
  • News FDA approves ella™ tablets for prescription emergency contraception

    The U.S. Food and Drug Administration today approved ella? (ulipristal acetate) tablets for emergency contraception. The prescription-only product prevents pregnancy when taken orally within 120 hours (five days) after a contraceptive failure or unprot...
  • News StemCells reports breakthrough using human neural stem cells to restore motor function in chronic spinal cord injury

    StemCells, Inc. announced the publication of new preclinical data demonstrating that the company’s proprietary human neural stem cells restore lost motor function in mice with chronic spinal cord injury.
  • News Genetix's ClonePix FL system gets US patent

    Genetix, a leading provider of solutions for imaging and image analysis, announces that it was granted a patent, US 7,776,584 on August 17, 2010. Aspects of this patent are incorporated into ClonePix FL, which is used for the screening and selection of...
  • News Strand inks pact with MSCC for translational cancer research, pilot study on head & neck cancer takes off

    Strand Life Sciences has entered into a strategic collaboration with Mazumdar Shaw Comprehensive Cancer Centre (MSCC), part of the multi-specialty hospital, Narayana Hrudalaya, in the area of translational cancer research.
  • News FDA Proposes Withdrawal of Low Blood Pressure Drug

    The U.S. Food and Drug Administration proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify the clinical benefit of ...
  • News Ipilimumab Receives FDA Priority Review Designation

    Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melano...
  • News A golden era for catalysts

    Nature’s keys – catalysts – can unlock doors to better product yields and faster reactions. Dr Sarah Houlton reviews the latest research using carbon nanofibres, enzymes and even gold for producing new catalysts.
  • News Moisture analysis

    Freelance Sarah Webster describes how Biopharma Technology is using laser-based headspace moisture analysis for rapid and non-destructive moisture determination of freeze-dried pharmaceutical products.